Trends in Diabetes-Related Preventable Hospitalizations in the U.S., 2005–2014
Diabetes-related preventable hospitalizations are indicators of effective primary care services (1), but recent trends are unknown. Hence, we examined the trends in diabetes-related preventable hospitalizations to critically inform policy decisions seeking accountability.
The current study used National (Nationwide) Inpatient Sample (NIS) data for assessing the trends in diabetes-related ;preventable hospitalization rates during the years 2005–2014. The NIS collected stratified samples of ∼20% of U.S. community hospital discharge data, which has been useful in calculating national estimates (2). The main outcomes included temporal trends in diabetes-related preventable hospitalization rates and associated conditions such as diabetes short-term complications, diabetes long-term complications, uncontrolled diabetes, lower-extremity amputations, and hospitalization costs. Yearly rates were calculated by dividing diabetes-related preventable hospitalizations and four diabetes-related Prevention Quality Indicators conditions by estimated number of adults aged ≥18 years with diagnosed diabetes obtained from National Health Interview Survey (NHIS) data.
A total of 5,399,199 diabetes-related preventable hospitalizations were reported as primary discharge diagnosis during the years 2005–2014. Diabetes-related preventable hospitalizations increased from 500,444 in 2005 to 577,040 in 2014. Age-adjusted diabetes-related preventable hospitalization rates did not change significantly during the study period (Ptrend = 0.279) (Fig. 1A). Diabetes-related preventable hospitalization rates decreased across all age-groups, except for an increase in the age-group 18–44 years, which was not significant (relative increase 20.5%; Ptrend = 0.052). The overall diabetes-related preventable hospitalization rates showed an annual percentage change of 1.0% (95% CI −0.9, 2.9; P = 0.300).
Diabetes-related preventable hospitalization rates, 2005–2014.
Age-adjusted hospitalization rates due to diabetes short-term complications increased significantly (relative increase 30.3%; Ptrend = 0.003) while those due to uncontrolled diabetes decreased significantly (relative increase 68.4%; Ptrend <0.001) (Fig. 1B). Hospitalization rates due to diabetes short-term complications increased across all age-groups, except for a nonsignificant decrease in the age-group ≥75 years (relative decrease 10.00%; Ptrend = 0.838). Hospitalization rates due to uncontrolled diabetes significantly decreased in all age-groups.
The mean length of stay decreased significantly from 5.7 to 5.3 days during the years 2005–2014 (relative decrease 7.5%; Ptrend <0.001). The total cost of hospitalizations due to diabetes-related preventable causes significantly increased from $5.32 to $6.28 billion during the study period (Ptrend = 0.042); however, mean hospitalization cost decreased significantly from $12,080 to $11,440 (Ptrend = 0.017).
Our study found that diabetes-related preventable hospitalization rates did not change significantly during the years 2005–2014, unlike the results in a previous study (3) that reported significantly decreasing trends. This could probably be due to a slight increase in hospitalization rates due to diabetes short-term complications balanced by a slight decrease in hospitalization rates due to uncontrolled diabetes. More importantly, we noted a significant increase in diabetes-related preventable hospitalizations due to acute complications in the age-group 18–44 years. Future interventions should focus on adequate management strategies in younger patients (18–44 years) because earlier control over the risk factors for microvascular and macrovascular processes could delay complications (4,5) and significantly decrease the prevalence of hospitalizations in this age-group. Further studies are needed to identify the underlying determinants of these trends so that primary care can focus on effective strategies to address these continuing challenges.
Article Information
Acknowledgments. The authors thank the millions of patients who contributed to the NIS database and the numerous professionals who created the database.
Duality of Interest. No potential conflicts of interest relevant to this article were reported.
Author Contributions. M.R. conceived the idea, and M.R., A.S., and V.R. wrote and edited the manuscript. R.K., J.H., and K.N. reviewed and edited the manuscript and contributed to the intellectual content. E.V. reviewed statistical analyses and edited the manuscript. M.R. and A.S. are the guarantors of this work and, as such, had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Footnotes
- Received September 17, 2017.
- Accepted December 31, 2017.
- © 2018 by the American Diabetes Association.
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.
In this Issue
